Aldebaran Capital’s OnKure Therapeutics, Inc. Class A Common Stock OKUR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $106K | Sell |
44,173
-875
| -2% | -$2.09K | 0.1% | 34 |
|
|
2025
Q1 | $194K | Sell |
45,048
-524
| -1% | -$2.25K | 0.18% | 39 |
|
|
2024
Q4 | $392K | Buy |
45,572
+360
| +0.8% | +$3.1K | 0.37% | 31 |
|
|
2024
Q3 | $769K | Buy |
45,212
+450
| +1% | +$7.65K | 0.7% | 25 |
|
|
2024
Q2 | $676K | Buy |
44,762
+5,121
| +13% | +$77.3K | 0.63% | 24 |
|
|
2024
Q1 | $658K | Buy |
+39,641
| New | +$658K | 0.63% | 23 |
|